These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
467 related items for PubMed ID: 8405239
1. Effects of recombinant human granulocyte-macrophage colony-stimulating factor on platelet survival and activation using a nonhuman primate model. Tomer A, Stahl CP, McClure HM, Anderson DC, Myers LA, Liehl E, Winton EF. Exp Hematol; 1993 Nov; 21(12):1577-82. PubMed ID: 8405239 [Abstract] [Full Text] [Related]
2. Measurements of in vivo megakaryocytopoiesis: studies in nonhuman primates and patients. Tomer A, Harker LA. Stem Cells; 1996 Nov; 14 Suppl 1():18-30. PubMed ID: 11012199 [Abstract] [Full Text] [Related]
3. Recombinant human interleukin 6 is a potent inducer of the acute phase response and elevates the blood platelets in nonhuman primates. Mayer P, Geissler K, Valent P, Ceska M, Bettelheim P, Liehl E. Exp Hematol; 1991 Aug; 19(7):688-96. PubMed ID: 1909969 [Abstract] [Full Text] [Related]
4. In vitro and in vivo activity of human recombinant granulocyte-macrophage colony-stimulating factor in dogs. Mayer P, Werner FJ, Lam C, Besemer J. Exp Hematol; 1990 Oct; 18(9):1026-33. PubMed ID: 2168838 [Abstract] [Full Text] [Related]
5. Recombinant human granulocyte-macrophage colony-stimulating factor promotes megakaryocyte maturation in nonhuman primates. Stahl CP, Winton EF, Monroe MC, Holman RC, Zelasky M, Liehl E, Myers LA, McClure H, Anderson D, Evatt BL. Exp Hematol; 1991 Sep; 19(8):810-6. PubMed ID: 1868895 [Abstract] [Full Text] [Related]
6. Phase I study of intravenously administered bacterially synthesized granulocyte-macrophage colony-stimulating factor and comparison with subcutaneous administration. Lieschke GJ, Maher D, O'Connor M, Green M, Sheridan W, Rallings M, Bonnem E, Burgess AW, McGrath K, Fox RM. Cancer Res; 1990 Feb 01; 50(3):606-14. PubMed ID: 2404573 [Abstract] [Full Text] [Related]
7. Peripheral blood stem cell acquisition by large-volume leukapheresis in growth factor-stimulated and unstimulated rhesus monkeys: development of an animal model. Hillyer CD, Swenson RB, Hart KK, Lackey DA, Winton EF. Exp Hematol; 1993 Oct 01; 21(11):1455-9. PubMed ID: 8405225 [Abstract] [Full Text] [Related]
8. In vivo stimulation of platelet production in a primate model using IL-1 and IL-3. Monroy RL, Davis TA, Donahue RE, MacVittie TJ. Exp Hematol; 1991 Aug 01; 19(7):629-35. PubMed ID: 1893949 [Abstract] [Full Text] [Related]
9. The effect of cytokines on the ploidy of megakaryocytes. Teramura M, Mizoguchi H. Int J Cell Cloning; 1990 Jul 01; 8(4):245-52. PubMed ID: 2205662 [Abstract] [Full Text] [Related]
11. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation. Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S. Exp Hematol; 1995 Dec 01; 23(14):1520-6. PubMed ID: 8542941 [Abstract] [Full Text] [Related]
12. Low-dose non-glycosylated rhGM-CSF is effective for the treatment of delayed hematopoietic recovery after autologous marrow or peripheral blood stem cell transplantation. Ippoliti C, Przepiorka D, Giralt S, Andersson BS, Wallerstein RO, Gutterman J, Deisseroth AB, Champlin RE. Bone Marrow Transplant; 1993 Jan 01; 11(1):55-9. PubMed ID: 8094309 [Abstract] [Full Text] [Related]
13. Lack of efficacy of thrombopoietin and granulocyte colony-stimulating factor after high dose total-body irradiation and autologous stem cell or bone marrow transplantation in rhesus monkeys. Neelis KJ, Dubbelman YD, Wognum AW, Thomas GR, Eaton DL, Egeland T, Wagemaker G. Exp Hematol; 1997 Sep 01; 25(10):1094-103. PubMed ID: 9293907 [Abstract] [Full Text] [Related]
14. Recovery from severe hematopoietic suppression using recombinant human granulocyte-macrophage colony-stimulating factor. Monroy RL, Skelly RR, Taylor P, Dubois A, Donahue RE, MacVittie TJ. Exp Hematol; 1988 Jun 01; 16(5):344-8. PubMed ID: 3286278 [Abstract] [Full Text] [Related]
15. Recombinant human granulocyte-macrophage colony-stimulating factor (CSF), but not recombinant human granulocyte CSF, down-regulates the recombinant human stem cell factor-dependent differentiation of human fetal liver-derived mast cells. Du Z, Li Y, Xia H, Irani AM, Schwartz LB. J Immunol; 1997 Jul 15; 159(2):838-45. PubMed ID: 9218602 [Abstract] [Full Text] [Related]
16. Granulocyte and granulocyte-macrophage colony-stimulating factors exert differential effects on neutrophil platelet-activating factor generation and release. Stewart AG, Cotterill T, Harris T. Immunology; 1994 May 15; 82(1):51-6. PubMed ID: 7519173 [Abstract] [Full Text] [Related]
17. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma. Arora M, Burns LJ, Barker JN, Miller JS, Defor TE, Olujohungbe AB, Weisdorf DJ. Biol Blood Marrow Transplant; 2004 Jun 15; 10(6):395-404. PubMed ID: 15148493 [Abstract] [Full Text] [Related]
18. Effect of in vivo administration of IL-3 and IL-6, alone and in combination with G-CSF, GM-CSF or IL-1, on haematopoiesis, graft-versus-host disease and survival after murine haematopoietic stem cell transplantation. Atkinson K, Vos B, Kang-Er Z, Guiffre A, Seymour R, Gillis S. Cytokines Mol Ther; 1995 Mar 15; 1(1):47-55. PubMed ID: 9384663 [Abstract] [Full Text] [Related]
19. rHuG-CSF increases the platelet-neutrophil complex formation and neutrophil adhesion molecule expression in volunteer granulocyte and stem cell apheresis donors. Karadogan C, Karadogan I, Bilgin AU, Undar L. Ther Apher Dial; 2006 Apr 15; 10(2):180-6. PubMed ID: 16684221 [Abstract] [Full Text] [Related]
20. Leridistim, a chimeric dual G-CSF and IL-3 receptor agonist, enhances multilineage hematopoietic recovery in a nonhuman primate model of radiation-induced myelosuppression: effect of schedule, dose, and route of administration. Farese AM, Casey DB, Smith WG, Vigneulle RM, McKearn JP, MacVittie TJ. Stem Cells; 2001 Apr 15; 19(6):522-33. PubMed ID: 11713344 [Abstract] [Full Text] [Related] Page: [Next] [New Search]